Cofco Biotechnology (000930.SZ) released its forecasted profit, expecting a net profit of 18-27 million yuan in 2024, turning losses into profits compared to the previous year.

Cofco Biotechnology (000930.SZ) announced its annual performance forecast for 2024, expecting a net profit attributable to shareholders of the listed company of 18-27 million yuan, turning losses into profits compared to the previous year. In 2024, the company closely monitors market changes, adjusts procurement and sales pace in a timely manner, utilizes "spot-futures integration" to control operational risks, continuously promotes low-cost systems and intensifies efforts to reduce consumption, leading to steady progress in operations.